Macquarie Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-66
| Closed | -$1.35K | – | 1691 |
|
|
2024
Q2 | $1.35K | Buy |
+66
| New | +$1.35K | ﹤0.01% | 1826 |
|
|
2022
Q4 | – | Sell |
-136
| Closed | -$28K | – | 1836 |
|
|
2022
Q3 | $28K | Sell |
136
-11
| -7% | -$2.27K | ﹤0.01% | 2092 |
|
|
2022
Q2 | $31K | Hold |
147
| – | – | ﹤0.01% | 2179 |
|
|
2022
Q1 | $49 | Hold |
147
| – | – | ﹤0.01% | 2141 |
|
|
2021
Q4 | $48K | Sell |
147
-53
| -27% | -$17.3K | ﹤0.01% | 2173 |
|
|
2021
Q3 | $97K | Buy |
200
+115
| +135% | +$55.8K | ﹤0.01% | 1990 |
|
|
2021
Q2 | $39K | Hold |
85
| – | – | ﹤0.01% | 2205 |
|
|
2021
Q1 | $58K | Buy |
85
+46
| +118% | +$31.4K | ﹤0.01% | 2032 |
|
|
2020
Q4 | $29K | Hold |
39
| – | – | ﹤0.01% | 2148 |
|
|
2020
Q3 | $27K | Hold |
39
| – | – | ﹤0.01% | 2090 |
|
|
2020
Q2 | $33K | Buy |
+39
| New | +$33K | ﹤0.01% | 2025 |
|